✦ LIBER ✦
Combined treatment using adoptive cell therapy, extended pharmacokinetic IL-2, and tumor-specific antibodies leads to cures of established B16F10 tumors and extended in vivo T cell survival
✍ Scribed by Cary F Opel,K Dane Wittrup
- Book ID
- 126381301
- Publisher
- Springer (Biomed Central Ltd.)
- Year
- 2013
- Tongue
- English
- Weight
- 98 KB
- Volume
- 1
- Category
- Article
- ISSN
- 2051-1426
No coin nor oath required. For personal study only.